According to a recent report by Market.us, the Global Drug Repurposing Market size is expected to be worth around USD 51.8 Billion by 2033 from USD 32.1 Billion in 2023, growing at a CAGR of 4.5% during the forecast period from 2024 to 2033.Drug repurposing, also known as drug repositioning or reprofiling, represent.
/PRNewswire/ TikoMed today announced the inclusion in bioRxiv of an in vitro study evaluating the ability of the company s lead drug candidate ILB® to:.
Adds further support for its broad-spectrum mechanism of action following other recent TBI, ALS and tropical virus studies VIKEN, Sweden, Sept. 13, 2022 /PRNewswire/ TikoMed today announced